BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 6623211)

  • 21. Evolving concepts of rheumatoid arthritis.
    Firestein GS
    Nature; 2003 May; 423(6937):356-61. PubMed ID: 12748655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunity in rheumatoid arthritis.
    Jiménez López A; Olmos Martínez JM
    Allergol Immunopathol (Madr); 1982; 10(6):471-9. PubMed ID: 6762823
    [No Abstract]   [Full Text] [Related]  

  • 23. [What significance for the etiology and pathogenesis of rheumatoid arthritis have: d) humoral immune processes].
    Müller W
    Verh Dtsch Ges Rheumatol; 1974; 3(0):22-5. PubMed ID: 4134848
    [No Abstract]   [Full Text] [Related]  

  • 24. Reduced complement-mediated immune complex solubilizing capacity and the presence of incompletely solubilized immune complexes in SLE sera.
    Baatrup G; Petersen I; Jensenius JC; Svehag SE
    Clin Exp Immunol; 1983 Nov; 54(2):439-47. PubMed ID: 6652967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IgG rheumatoid factor, complement and immune complexes in rheumatoid synovitis and vasculitis: comparative and serial studies during cytotoxic therapy.
    Scott DG; Bacon PA; Allen C; Elson CJ; Wallington T
    Clin Exp Immunol; 1981 Jan; 43(1):54-63. PubMed ID: 7249394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune complex activation of neutrophils and enhancement of the activation by rheumatoid factor and complement.
    Gale RJ; Nikoloutsopoulos A; Bradley J; Roberts-Thomson PJ
    J Rheumatol; 1985 Feb; 12(1):21-6. PubMed ID: 2580091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunologic dynamics in cryapheresis for rheumatoid arthritis.
    Wallace DJ; Barnett EV; Nichols S; Hancock W; Vibert G; Curd J; Klinenberg JR; Goldfinger D
    J Rheumatol; 1983 Dec; 10(6):894-900. PubMed ID: 6607341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased complement mediated binding of antibody/3H-dsDNA immune complexes to the red blood cells of patients with systemic lupus erythematosus, rheumatoid arthritis, and hematologic malignancies.
    Taylor RP; Horgan C; Buschbacher R; Brunner CM; Hess CE; O'Brien WM; Wanebo HJ
    Arthritis Rheum; 1983 Jun; 26(6):736-44. PubMed ID: 6860375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rheumatoid factor and complement activation.
    Doekes G; Hiemstra PS
    Monogr Allergy; 1989; 26():82-95. PubMed ID: 2671694
    [No Abstract]   [Full Text] [Related]  

  • 30. [Complement system: an ingenious biochemical mechanism, a co-participant in the natural defense and a mediator of cell interaction].
    Dias da Silva W; Kipnis TL
    AMB Rev Assoc Med Bras; 1984; 30(3-4):67-72. PubMed ID: 6382459
    [No Abstract]   [Full Text] [Related]  

  • 31. [Immune complex in diagnosis].
    Wager O; Penttinen K; Tallgren LG
    Duodecim; 1973; 89(2):113-21. PubMed ID: 4685129
    [No Abstract]   [Full Text] [Related]  

  • 32. [Immunologic defense mechanism in the solubilization of immune complexes by complement].
    Tomooka K; Yasuda M; Nobunaga M; Sakai K
    Nihon Rinsho; 1988 Sep; 46(9):1968-73. PubMed ID: 3241388
    [No Abstract]   [Full Text] [Related]  

  • 33. Immune complexes from rheumatoid arthritis synovial fluid induce FcgammaRIIa dependent and rheumatoid factor correlated production of tumour necrosis factor-alpha by peripheral blood mononuclear cells.
    Mathsson L; Lampa J; Mullazehi M; Rönnelid J
    Arthritis Res Ther; 2006; 8(3):R64. PubMed ID: 16569263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immunologic processes in chronic inflammatory rheumatic diseases].
    Zivković M
    Reumatizam; 1981; 28(6):183-92. PubMed ID: 7323497
    [No Abstract]   [Full Text] [Related]  

  • 35. [Complement enables the physiological elimination of immune complexes].
    Schifferli JA
    Ther Umsch; 1988 Feb; 45(2):74-8. PubMed ID: 3358245
    [No Abstract]   [Full Text] [Related]  

  • 36. Anti-Fc gamma receptor III autoantibody is associated with soluble receptor in rheumatoid arthritis serum and synovial fluid.
    Lamour A; Baron D; Soubrane C; Cartron J; Khayat D; Adler Y; Le Goff P; Youinou P
    J Autoimmun; 1995 Apr; 8(2):249-65. PubMed ID: 7612151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Etiology and pathogenesis of rheumatoid arthritis. Current lines of investigation.
    McDuffie FC
    Orthop Clin North Am; 1971 Nov; 2(3):601-12. PubMed ID: 4942576
    [No Abstract]   [Full Text] [Related]  

  • 38. [Interrelation of autoimmune and immune complex pathology: the current status of the problem].
    Nasonov EL; Sura VV
    Ter Arkh; 1984; 56(10):4-10. PubMed ID: 6240791
    [No Abstract]   [Full Text] [Related]  

  • 39. [Circulating immune complexes in rheumatic diseases].
    Nasonov EL; Sura VV; Borisov IA; Timofeeva EB
    Ter Arkh; 1981; 53(12):118-27. PubMed ID: 7336334
    [No Abstract]   [Full Text] [Related]  

  • 40. An allergic concept of the etiology of rheumatoid arthritis.
    Millman M
    Ann Allergy; 1972 Mar; 30(3):135-41. PubMed ID: 4110915
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.